July 31, 2012 — Elekta is showcasing its Agility multileaf collimator (MLC) at the 2012 American Association of Physicists in Medicine (AAPM) annual meeting in Charlotte, N.C. Using a combination of 160 high-resolution tungsten leaves and dramatically faster leaf movement, Agility promises a new level of precision and delivery speed in radiation therapy treatments for cancer patients. The system recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Agility is Elekta's latest addition to its comprehensive portfolio of integrated oncology care solutions. Using twice the number of leaves typical of standard MLCs, Agility precisely and rapidly sculpts delivered radiation to the unique contours of tumors while reducing radiation exposure to healthy tissues. With its lower radiation leakage design, research has shown Agility can significantly reduce the patient’s non-therapeutic radiation exposure as compared to other conventional MLCs.
Combining Agility with Monaco treatment planning — particularly for volumetric modulated arc therapy (VMAT) plans — can dramatically improve planning and delivery efficiency. The latest version of Monaco includes a new segment shape optimization (SSO) feature that produces high-quality VMAT plans. Monaco 3.2 plans delivery of the maximum dose to the tumor while avoiding dose to surrounding areas, while VMAT delivery ensures dose is delivered quickly to minimize treatment times.
Elekta is also showcasing its Mosaiq oncology information system, Monaco treatment planning system with VMAT and Infinity treatment system at AAPM 2012. Other exhibition highlights include:
- Clarity Autoscan, which enables real-time soft tissue tracking for prostate motion during treatment;
- Mosaiq Mobile, providing instant access to Mosaiq from anywhere;
- Oncentra Brachy treatment planning platform, delivering pinpoint accuracy and treatment confidence; and
- Leksell GammaPlan Gamma Knife treatment planning system, offering speed and accuracy.
Mosaiq Mobile and Clarity Autoscan are works in progress and not for sale in all markets. Agility and Oncentra Brachy are not for sale in all markets.
For more information: www.elekta.com
April 25, 2024 
